Skip to contentM
Medtronic plc
M
MDTMedtronic plc Q4 2026 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$9.81B$9.81Bderived+9.9% vs Q4 2025 Net Income$1.24B$1.24Bderived+17.8% vs Q4 2025 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medtronic plc · CIK 1613103 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$1,872,000,000+30.4% Operating Cash Flowderived$2,573,000,000+1.8% Free Cash Flowderived$2,085,000,000+0.8% Margins · derivedOperating margin19.1%+3.0 pt vs Q4 2025
Net margin12.7%+0.9 pt vs Q4 2025
ended Apr 24, 2026 · filed Jun 18, 2026 · 55 d after period end